High-dose interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma: still the standard.
Year: 2011
Type: article
Source: PubMed
Author: Janice P Dutcher
Institution: St. Luke's-Roosevelt Hospital Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2406671706